Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
NCT00071851
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
180
Enrollment
NIH
Sponsor class
Conditions
HIV Infections
Interventions
BIOLOGICAL:
VRC-HIVDNA009-00-VP
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)